Ninerafaxstat Shows Promise in Phase 2 IMPROVE-HCM Trial for Nonobstructive HCM
Martin Maron, MD, discusses the results of the IMPROVE-HCM trial and how it informs the community on the potential of plozasiran.
Source: hcplive.com
Page 3 - Standard Deviation News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Standard Deviation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Standard Deviation Today - Breaking & Trending Today
MAH 3-year LLB CET Answer Key Objection Window Closes Tomorrow, Check Equated Score Computation Method
MAH CET 2024 3-year LLB answer key objection window will close tomorrow April 3, 2024. Students can raise objections through the candidate login link provided here.
Source: jagranjosh.com
Food as Medicine Programs Could Address Food Insecurity, Improve Cardiovascular Health
Implementing a Food as Medicine program improved diet, physical activity, and reduced cardiovascular risk factors among participants.
Source: hcplive.com
CUET UG Maths 2024: Check last year's syllabus for this paper
News News: The National Testing Agency has started the application procedure for the Common University Entrance Test for Undergraduate courses (CUET UG 2024). Re
Source: indiatimes.com
MANDARA: Benralizumab Proves Noninferiority to Mepolizumab for EGPA
The MANDARA trial results, published in NEJM, show benralizumab's noninferiority to mepolizumab in eosinophilic granulomatosis with polyangiitis, with potential for oral glucocorticoid discontinuation.
Source: hcplive.com